Business: The billion-dollar biotech
@article{Dolgin2015BusinessTB, title={Business: The billion-dollar biotech}, author={Elie S Dolgin}, journal={Nature}, year={2015}, volume={522}, pages={26-28} }
Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.
14 Citations
Nanotechnology-Based Weapons: A Potential Approach for COVID-19
- MedicineThe Open COVID Journal
- 2021
The present review particularly emphasizes the perception of several nanoformulation-based approaches as an appropriate means to safeguard mankind against COVID-19.
Introduction to RNA Vaccines.
- BiologyMethods in molecular biology
- 2017
In this chapter, key developments in RNA vaccines are reviewed and the contents of this volume of Methods in Molecular Biology are outlined.
Alternative strategies in cardiac preclinical research and new clinical trial formats
- BiologyCardiovascular research
- 2021
This work examines recent gold standard randomized clinical trials and presents possible modifications to increase lead candidate throughput: adaptive designs, master protocols and drug repurposing.
Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment
- BiologyNanomaterials
- 2021
This review article comprehensively discusses the use of nanotechnology for COVID-19 based on three main categories: prevention, diagnostics and treatment and critically review the benefits of nanomaterials along with their applications in personal protective equipment, vaccine development, diagnostic device fabrication and therapeutic approaches.
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
- BiologyACS nano
- 2020
Nanoimmunity by design can help to design materials for immune modulation, either stimulating or suppressing the immune response, which would find applications in the context of vaccine development for SARS-CoV-2 or in counteracting the cytokine storm, respectively.
mRNA-Based Genetic Reprogramming.
- BiologyMolecular therapy : the journal of the American Society of Gene Therapy
- 2019
ER Intrabodies: Potent Molecules for Specific Knockdown of Proteins Passingthe ER
- Biology
- 2015
A very promising protein knockdown technique is based on recombinant antibody fragments expressed inside the ER (ER intrabodies). ER intrabodies mediate inhibition of the function of proteins passing…
Single domain antibodies for the knockdown of cytosolic and nuclear proteins
- Biology, ChemistryProtein science : a publication of the Protein Society
- 2017
The development of new endosomal escape protein domains and cell‐penetrating peptides for efficient transfection broaden the application of inhibiting sdAbs, and the generation of relatively new cell‐specific nanoparticles such as polymersomes and polyplexes carrying cytosolic/nuclear sdAb‐DNA or –protein will pave the way to apply cytosol/ nuclear sdAbs for inhibition of viral infection and cancer in the clinic.
Single domain antibodies for the knockdown of cytosolic and nuclear proteins.
- Biology, Chemistry
- 2017
The development of new endosomal escape protein domains and cell-penetrating peptides for efficient transfection broaden the application of inhibiting sdAbs, and the generation of relatively new cell-specific nanoparticles such as polymersomes and polyplexes carrying cytosolic/nuclear sdAb-DNA or -protein will pave the way for inhibition of viral infection and cancer in the clinic.
ER-targeted Intrabodies Mediating Specific In Vivo Knockdown of Transitory Proteins in Comparison to RNAi
- Biology, Chemistry
- 2016
Specificity and off-target effects (OTE) of these molecules as well as the therapeutic potential of ER intrabodies and RNAi have been compared.
References
SHOWING 1-7 OF 7 REFERENCES
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
- BiologyMolecular therapy : the journal of the American Society of Gene Therapy
- 2008
It is found that mRNAs containing pseudouridines have a higher translational capacity than unmodified m RNAs when tested in mammalian cells and lysates or administered intravenously into mice at 0.015-0.15 mg/kg doses.
Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
- BiologyMolecular therapy : the journal of the American Society of Gene Therapy
- 2012
Results demonstrate that HPLC-purified, pseudouridine-containing mRNAs encoding therapeutic proteins have great potential for clinical applications and are evaluated using erythropoietin (EPO)-encoding mRNA complexed with TransIT-mRNA.
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.
- BiologyImmunity
- 2005
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
- BiologyNature Biotechnology
- 2013
It is shown that intramyocardial injection of synthetic modified RNA (modRNA) encoding human vascular endothelial growth factor-A (VEGF-A) results in the expansion and directed differentiation of endogenous heart progenitors in a mouse myocardial infarction model.
Direct gene transfer into mouse muscle in vivo.
- BiologyScience
- 1990
RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and beta-galactosidase were separately injected into mouse skeletal muscle in vivo and expression was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions.
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
- BiologyCell stem cell
- 2010
Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.
- BiologyScience
- 1992
In Brattleboro rats, injection into the hypothalamus of purified mRNAs from normal rat hypothalami or of synthetic copies of the vasopressin mRNA leads to selective uptake, retrograde transport, and expression of vasoppressin exclusively in the magnocellular neurons.